Lipoproteins as drug delivery vehicles for cancer and tumor therapeutics

R. Upadhyay
{"title":"Lipoproteins as drug delivery vehicles for cancer and tumor therapeutics","authors":"R. Upadhyay","doi":"10.15406/JSRT.2018.04.00115","DOIUrl":null,"url":null,"abstract":"Lipoproteins are biological lipid carriers play important role in transport of fats within the body.1 These are natural nanoparticles which serve as drug-delivery vehicles due to their small size, long residence time in the circulation.2 Low-density lipoprotein (LDL) carries cholesterol in plasma3 and play important role in its metabolism in normal cells as well as in cancer cells.4 Lipoproteins carry highdrug payload and are used as delivery vehicles for transportation of chemotherapeutic agents. These bear unique targeting capabilities because of their easy transportation to cancer and tumor sites. LDL loaded with r11-DOX is used to treat cancer cells. LDL follows receptor pathway is used to deliver radionucleotides for the treatment of neoplasms and tumors.5 Both liposomes and oil emulsions are also used to carry water-insoluble photosensitizers for treatment of tumors.6 Besides, low-density lipoproteins (LDLs) monoclonal antibodies are also most promising delivery vehicles for anticancer drugs. For delivery of therapeutic agents liposomes bind to some antibody and loaded drug are internalized by into macrophages via the receptor-mediated pathway for modified LDL.7 More specifically, loaded drug is assimilated through receptor-mediated pathway in cancer cells and its rate is much higher than that of normal cells. For transport of drugs to new targets, lipoproteins are bound to ligands. Lipoproteins structure is modified to tag nucleic acids, photosensitizers for therapeutics. These also act as biophysical devices like contrast agents and can be loaded with drugs, LPs and phospholipids. These natural drug nanocarriers escape any interaction with immune cells and reticuloendothelial systems.8 Hence, drugs loaded on LDLs safely transported to tumor cells without loss of their activity.9 After receptor-mediated uptake of drug-lipoprotein complex escape enzyme attack.2 Lipoproteins are safe, biocompatible, biodegradable, nonimmunogenic and successfully carry diverse therapeutic molecules to the site of invasion. Lipoproteins: transport vehicles of lipids","PeriodicalId":91560,"journal":{"name":"Journal of stem cell research & therapeutics","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stem cell research & therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JSRT.2018.04.00115","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Lipoproteins are biological lipid carriers play important role in transport of fats within the body.1 These are natural nanoparticles which serve as drug-delivery vehicles due to their small size, long residence time in the circulation.2 Low-density lipoprotein (LDL) carries cholesterol in plasma3 and play important role in its metabolism in normal cells as well as in cancer cells.4 Lipoproteins carry highdrug payload and are used as delivery vehicles for transportation of chemotherapeutic agents. These bear unique targeting capabilities because of their easy transportation to cancer and tumor sites. LDL loaded with r11-DOX is used to treat cancer cells. LDL follows receptor pathway is used to deliver radionucleotides for the treatment of neoplasms and tumors.5 Both liposomes and oil emulsions are also used to carry water-insoluble photosensitizers for treatment of tumors.6 Besides, low-density lipoproteins (LDLs) monoclonal antibodies are also most promising delivery vehicles for anticancer drugs. For delivery of therapeutic agents liposomes bind to some antibody and loaded drug are internalized by into macrophages via the receptor-mediated pathway for modified LDL.7 More specifically, loaded drug is assimilated through receptor-mediated pathway in cancer cells and its rate is much higher than that of normal cells. For transport of drugs to new targets, lipoproteins are bound to ligands. Lipoproteins structure is modified to tag nucleic acids, photosensitizers for therapeutics. These also act as biophysical devices like contrast agents and can be loaded with drugs, LPs and phospholipids. These natural drug nanocarriers escape any interaction with immune cells and reticuloendothelial systems.8 Hence, drugs loaded on LDLs safely transported to tumor cells without loss of their activity.9 After receptor-mediated uptake of drug-lipoprotein complex escape enzyme attack.2 Lipoproteins are safe, biocompatible, biodegradable, nonimmunogenic and successfully carry diverse therapeutic molecules to the site of invasion. Lipoproteins: transport vehicles of lipids
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脂蛋白作为癌症和肿瘤治疗的药物传递载体
脂蛋白是生物脂质载体,在体内脂肪的运输中起着重要作用这些是天然的纳米颗粒,由于它们体积小,在循环中停留时间长,可以作为药物输送载体低密度脂蛋白(LDL)在血浆中携带胆固醇,在正常细胞和癌细胞的代谢中起重要作用脂蛋白携带高药物载荷,是化疗药物运输的运载工具。它们具有独特的靶向能力,因为它们易于运输到癌症和肿瘤部位。LDL装载r11-DOX用于治疗癌细胞。低密度脂蛋白跟随受体途径被用于传递放射性核苷酸,用于肿瘤和肿瘤的治疗脂质体和油乳剂也用于携带水不溶性光敏剂治疗肿瘤此外,低密度脂蛋白(ldl)单克隆抗体也是最有前途的抗癌药物递送载体。为了递送治疗剂,脂质体结合某些抗体和载药通过受体介导的途径内化到巨噬细胞中,以修饰ldl。更具体地说,载药通过受体介导的途径在癌细胞中被吸收,其吸收率远高于正常细胞。为了将药物运输到新的靶点,脂蛋白与配体结合。修饰脂蛋白结构以标记核酸,光敏剂用于治疗。它们也像造影剂一样作为生物物理设备,可以装载药物、脂多糖和磷脂。这些天然药物纳米载体可避免与免疫细胞和网状内皮系统相互作用因此,装载在ldl上的药物安全运输到肿瘤细胞而不丧失其活性受体介导的药物-脂蛋白复合物摄取后逃逸酶攻击脂蛋白是安全的、生物相容性的、可生物降解的、非免疫原性的,并能成功地将各种治疗分子运送到侵袭部位。脂蛋白:脂质的运输载体
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Echinacea purpurea, a pathway to increased immunity Inhibition of cancer promoting proteins An in-vitro study of Amniotic membrane, Villous chorion and Wharton’s jelly-derived Mesenchymal stem cells and their potential for cardiac repair Attempt to regenerate the dog’s tooth using the method of a new direction in biology‒Linguistic‒Wave Genetics Prevention and treatment of cerebral palsy caused by intrapartum damage with novel hypoxia index
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1